<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>PURPOSE OF REVIEW: Implantable cardioverter-defibrillator (<z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">ICD</z:e>) implantation is the standard of care for secondary prevention in patients with previous <z:hpo ids='HP_0001695'>cardiac arrest</z:hpo> and for primary prevention in appropriately selected patients with <z:hpo ids='HP_0001638'>cardiomyopathy</z:hpo> </plain></SENT>
<SENT sid="1" pm="."><plain>However, <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">ICD</z:e> therapies and the <z:hpo ids='HP_0011675'>arrhythmias</z:hpo> that trigger these therapies cause decreased quality of life as well as increased morbidity and mortality </plain></SENT>
<SENT sid="2" pm="."><plain>In this review, we summarize the recent evidence for interventions that may prevent <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">ICD</z:e> therapies </plain></SENT>
<SENT sid="3" pm="."><plain>RECENT FINDINGS: Pharmacologic therapy remains central to prevent <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">ICD</z:e> shocks, but there is limited new evidence for drug therapies </plain></SENT>
<SENT sid="4" pm="."><plain>Programming techniques continue to evolve which decrease the risk of inappropriate shocks </plain></SENT>
<SENT sid="5" pm="."><plain>Cardiac resynchronization therapy (CRT) improves quality of life and decreases mortality, at least in part because of decreased <z:hpo ids='HP_0011675'>arrhythmia</z:hpo> burden </plain></SENT>
<SENT sid="6" pm="."><plain>Procedures such as catheter ablation of <z:hpo ids='HP_0004756'>ventricular tachycardia</z:hpo> and procedures to modulate the autonomic <z:mp ids='MP_0008912'>nervous</z:mp> system can help minimize <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">ICD</z:e> therapy </plain></SENT>
<SENT sid="7" pm="."><plain>SUMMARY: Pharmacologic therapy and appropriate device programming remain essential to the overall care of <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">ICD</z:e> patients </plain></SENT>
<SENT sid="8" pm="."><plain>The role of CRT continues to grow as we gain a better understanding of its benefits </plain></SENT>
<SENT sid="9" pm="."><plain>Advancements in the fields of catheter ablation and new understanding of the autonomic <z:mp ids='MP_0008912'>nervous</z:mp> system's effects on <z:hpo ids='HP_0004308'>ventricular arrhythmias</z:hpo> allow interventions to decrease the frequency of <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">ICD</z:e> shocks </plain></SENT>
</text></document>